East Bay biotech's different approach to cancer leads to $80 million IPO
August 23, 2018 at 17:47 PM EDT
The company is the 12th Bay Area life sciences company to file to go public in 2018.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.